Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 201

1.

Net Benefits of Recovery High Schools: Higher Cost but Increased Sobriety and Educational Attainment.

Weimer DL, Moberg P, French F, Tanner-Smith EE, Finch AJ.

J Ment Health Policy Econ. 2019 Sep 1;22(3):109-120.

2.

A Quantitative Meta-analysis of Olfactory Dysfunction in Epilepsy.

Khurshid K, Crow AJD, Rupert PE, Minniti NL, Carswell MA, Mechanic-Hamilton DJ, Kamath V, Doty RL, Moberg PJ, Roalf DR.

Neuropsychol Rev. 2019 Sep;29(3):328-337. doi: 10.1007/s11065-019-09406-7. Epub 2019 May 29. Review.

PMID:
31144106
3.

Olfactory deficits and psychosis-spectrum symptoms in 22q11.2 deletion syndrome.

Tang SX, Moberg PJ, Yi JJ, Wiemken AS, Dress EM, Moore TM, Calkins ME, McDonald-McGinn DM, Zackai EH, Emanuel BS, Gur RC, Gur RE, Turetsky BI.

Schizophr Res. 2018 Dec;202:113-119. doi: 10.1016/j.schres.2018.07.012. Epub 2018 Jul 11.

4.

Determining a Short Form Montreal Cognitive Assessment (s-MoCA) Czech Version: Validity in Mild Cognitive Impairment Parkinson's Disease and Cross-Cultural Comparison.

Bezdicek O, Červenková M, Moore TM, Stepankova Georgi H, Sulc Z, Wolk DA, Weintraub DA, Moberg PJ, Jech R, Kopecek M, Roalf DR.

Assessment. 2018 Jun 1:1073191118778896. doi: 10.1177/1073191118778896. [Epub ahead of print]

5.

Neurocognitive Functioning in Patients with 22q11.2 Deletion Syndrome: A Meta-Analytic Review.

Moberg PJ, Richman MJ, Roalf DR, Morse CL, Graefe AC, Brennan L, Vickers K, Tsering W, Kamath V, Turetsky BI, Gur RC, Gur RE.

Behav Genet. 2018 Jul;48(4):259-270. doi: 10.1007/s10519-018-9903-5. Epub 2018 Jun 19. Review.

PMID:
29922984
6.

Influences of temporal lobe epilepsy and temporal lobe resection on olfaction.

Doty RL, Tourbier I, Neff JK, Silas J, Turetsky B, Moberg P, Kim T, Pluta J, French J, Sharan AD, Sperling MJ, Mirza N, Risser A, Baltuch G, Detre JA.

J Neurol. 2018 Jul;265(7):1654-1665. doi: 10.1007/s00415-018-8891-y. Epub 2018 May 16.

7.

Quantitative assessment of finger tapping characteristics in mild cognitive impairment, Alzheimer's disease, and Parkinson's disease.

Roalf DR, Rupert P, Mechanic-Hamilton D, Brennan L, Duda JE, Weintraub D, Trojanowski JQ, Wolk D, Moberg PJ.

J Neurol. 2018 Jun;265(6):1365-1375. doi: 10.1007/s00415-018-8841-8. Epub 2018 Apr 4.

8.

Older Adult Normative Data for the Sniffin' Sticks Odor Identification Test.

Vickers KL, Breslin K, Roalf DR, Kamath V, Xie SX, Moberg PJ, Wolk DA, Mechanic-Hamilton D.

Arch Clin Neuropsychol. 2019 Mar 1;34(2):254-258. doi: 10.1093/arclin/acy021.

9.

Olfactory processing in bipolar disorder, major depression, and anxiety.

Kamath V, Paksarian D, Cui L, Moberg PJ, Turetsky BI, Merikangas KR.

Bipolar Disord. 2018 Sep;20(6):547-555. doi: 10.1111/bdi.12625. Epub 2018 Feb 13.

PMID:
29441710
10.

Structural anomalies of the peripheral olfactory system in psychosis high-risk subjects.

Turetsky BI, Moberg PJ, Quarmley M, Dress E, Calkins ME, Ruparel K, Prabhakaran K, Gur RE, Roalf DR.

Schizophr Res. 2018 May;195:197-205. doi: 10.1016/j.schres.2017.09.015. Epub 2017 Sep 30.

11.

Neuropsychological Subgroups in Non-Demented Parkinson's Disease: A Latent Class Analysis.

Brennan L, Devlin KM, Xie SX, Mechanic-Hamilton D, Tran B, Hurtig HH, Chen-Plotkin A, Chahine LM, Morley JF, Duda JE, Roalf DR, Dahodwala N, Rick J, Trojanowski JQ, Moberg PJ, Weintraub D.

J Parkinsons Dis. 2017;7(2):385-395. doi: 10.3233/JPD-171081.

12.

Bridging cognitive screening tests in neurologic disorders: A crosswalk between the short Montreal Cognitive Assessment and Mini-Mental State Examination.

Roalf DR, Moore TM, Mechanic-Hamilton D, Wolk DA, Arnold SE, Weintraub DA, Moberg PJ.

Alzheimers Dement. 2017 Aug;13(8):947-952. doi: 10.1016/j.jalz.2017.01.015. Epub 2017 Feb 24.

13.

Glutamate imaging (GluCEST) reveals lower brain GluCEST contrast in patients on the psychosis spectrum.

Roalf DR, Nanga RPR, Rupert PE, Hariharan H, Quarmley M, Calkins ME, Dress E, Prabhakaran K, Elliott MA, Moberg PJ, Gur RC, Gur RE, Reddy R, Turetsky BI.

Mol Psychiatry. 2017 Sep;22(9):1298-1305. doi: 10.1038/mp.2016.258. Epub 2017 Jan 24.

14.

A quantitative meta-analysis of olfactory dysfunction in mild cognitive impairment.

Roalf DR, Moberg MJ, Turetsky BI, Brennan L, Kabadi S, Wolk DA, Moberg PJ.

J Neurol Neurosurg Psychiatry. 2017 Mar;88(3):226-232. doi: 10.1136/jnnp-2016-314638. Epub 2016 Dec 30. Review.

15.

Odor Identification Screening Improves Diagnostic Classification in Incipient Alzheimer's Disease.

Quarmley M, Moberg PJ, Mechanic-Hamilton D, Kabadi S, Arnold SE, Wolk DA, Roalf DR.

J Alzheimers Dis. 2017;55(4):1497-1507. doi: 10.3233/JAD-160842.

16.

Unilateral olfactory sensitivity in multiple sclerosis.

Good KP, Tourbier IA, Moberg P, Cuzzocreo JL, Geckle RJ, Yousem DM, Pham DL, Doty RL.

Physiol Behav. 2017 Jan 1;168:24-30. doi: 10.1016/j.physbeh.2016.10.017. Epub 2016 Oct 22.

17.

Cognitive outcome after ventral capsule/ventral striatum stimulation for treatment-resistant major depression.

Kubu CS, Brelje T, Butters MA, Deckersbach T, Malloy P, Moberg P, Tröster AI, Williamson E, Baltuch GH, Bhati MT, Carpenter LL, Dougherty DD, Howland RH, Rezai AR, Malone DA Jr.

J Neurol Neurosurg Psychiatry. 2017 Mar;88(3):262-265. doi: 10.1136/jnnp-2016-313803. Epub 2016 Sep 22.

PMID:
27659923
18.

Within-Individual Variability: An Index for Subtle Change in Neurocognition in Mild Cognitive Impairment.

Roalf DR, Quarmley M, Mechanic-Hamilton D, Wolk DA, Arnold SE, Moberg PJ; Alzheimer’s Disease Neuroimaging Initiative.

J Alzheimers Dis. 2016 Aug 10;54(1):325-35. doi: 10.3233/JAD-160259.

19.

Temporal Lobe Volume Decrements in Psychosis Spectrum Youths.

Roalf DR, Quarmley M, Calkins ME, Satterthwaite TD, Ruparel K, Elliott MA, Moore TM, Gur RC, Gur RE, Moberg PJ, Turetsky BI.

Schizophr Bull. 2017 May 1;43(3):601-610. doi: 10.1093/schbul/sbw112.

20.

Hearing the Signs of Age-Related Cognitive Decline: A Commentary on "Hearing Aid Use Is Associated with Better Mini-Mental State Exam Performance".

Roalf DR, Moberg PJ.

Am J Geriatr Psychiatry. 2016 Sep;24(9):703-5. doi: 10.1016/j.jagp.2016.04.010. Epub 2016 Apr 29. No abstract available.

21.

Defining and validating a short form Montreal Cognitive Assessment (s-MoCA) for use in neurodegenerative disease.

Roalf DR, Moore TM, Wolk DA, Arnold SE, Mechanic-Hamilton D, Rick J, Kabadi S, Ruparel K, Chen-Plotkin AS, Chahine LM, Dahodwala NA, Duda JE, Weintraub DA, Moberg PJ.

J Neurol Neurosurg Psychiatry. 2016 Dec;87(12):1303-1310. doi: 10.1136/jnnp-2015-312723. Epub 2016 Apr 12.

22.

A saposin-lipoprotein nanoparticle system for membrane proteins.

Frauenfeld J, Löving R, Armache JP, Sonnen AF, Guettou F, Moberg P, Zhu L, Jegerschöld C, Flayhan A, Briggs JA, Garoff H, Löw C, Cheng Y, Nordlund P.

Nat Methods. 2016 Apr;13(4):345-51. doi: 10.1038/nmeth.3801. Epub 2016 Mar 7.

24.

Memantine and Cognition in Parkinson's Disease Dementia/Dementia With Lewy Bodies: A Meta-Analysis.

Brennan L, Pantelyat A, Duda JE, Morley JF, Weintraub D, Wilkinson JR, Moberg PJ.

Mov Disord Clin Pract. 2015 Dec 7;3(2):161-167. doi: 10.1002/mdc3.12264. eCollection 2016 Mar-Apr.

25.

Altered G Protein Coupling in Olfactory Neuroepithelial Cells From Patients With Schizophrenia.

Borgmann-Winter KE, Wang HY, Ray R, Willis BR, Moberg PJ, Rawson NE, Gur RE, Turetsky BI, Hahn CG.

Schizophr Bull. 2016 Mar;42(2):377-85. doi: 10.1093/schbul/sbv129. Epub 2015 Sep 15.

26.

P50: A candidate ERP biomarker of prodromal Alzheimer's disease.

Green DL, Payne L, Polikar R, Moberg PJ, Wolk DA, Kounios J.

Brain Res. 2015 Oct 22;1624:390-397. doi: 10.1016/j.brainres.2015.07.054. Epub 2015 Aug 6.

27.

Influences of hormone replacement therapy on olfactory and cognitive function in postmenopausal women.

Doty RL, Tourbier I, Ng V, Neff J, Armstrong D, Battistini M, Sammel MD, Gettes D, Evans DL, Mirza N, Moberg PJ, Connolly T, Sondheimer SJ.

Neurobiol Aging. 2015 Jun;36(6):2053-9. doi: 10.1016/j.neurobiolaging.2015.02.028. Epub 2015 Mar 10.

28.

Conversion between mini-mental state examination, montreal cognitive assessment, and dementia rating scale-2 scores in Parkinson's disease.

van Steenoven I, Aarsland D, Hurtig H, Chen-Plotkin A, Duda JE, Rick J, Chahine LM, Dahodwala N, Trojanowski JQ, Roalf DR, Moberg PJ, Weintraub D.

Mov Disord. 2014 Dec;29(14):1809-15. doi: 10.1002/mds.26062. Epub 2014 Nov 7.

29.

Selectivity mechanism of a bacterial homolog of the human drug-peptide transporters PepT1 and PepT2.

Guettou F, Quistgaard EM, Raba M, Moberg P, Löw C, Nordlund P.

Nat Struct Mol Biol. 2014 Aug;21(8):728-31. doi: 10.1038/nsmb.2860. Epub 2014 Jul 27.

PMID:
25064511
30.

A team approach to systematic behavioral screening and intervention.

Brown RL, Moberg PD, Allen JB, Peterson CT, Saunders LA, Croyle MD, Lecoanet RM, Linnan SM, Briedenbach K, Caldwell SB.

Am J Manag Care. 2014 Apr 1;20(4):e113-21.

31.

Facial emotion perception differs in young persons at genetic and clinical high-risk for psychosis.

Kohler CG, Richard JA, Brensinger CM, Borgmann-Winter KE, Conroy CG, Moberg PJ, Gur RC, Gur RE, Calkins ME.

Psychiatry Res. 2014 May 15;216(2):206-12. doi: 10.1016/j.psychres.2014.01.023. Epub 2014 Jan 23.

PMID:
24582775
32.

Neurocognitive development in 22q11.2 deletion syndrome: comparison with youth having developmental delay and medical comorbidities.

Gur RE, Yi JJ, McDonald-McGinn DM, Tang SX, Calkins ME, Whinna D, Souders MC, Savitt A, Zackai EH, Moberg PJ, Emanuel BS, Gur RC.

Mol Psychiatry. 2014 Nov;19(11):1205-11. doi: 10.1038/mp.2013.189. Epub 2014 Jan 21.

33.

Nanobody mediated crystallization of an archeal mechanosensitive channel.

Löw C, Yau YH, Pardon E, Jegerschöld C, Wåhlin L, Quistgaard EM, Moberg P, Geifman-Shochat S, Steyaert J, Nordlund P.

PLoS One. 2013 Oct 21;8(10):e77984. doi: 10.1371/journal.pone.0077984. eCollection 2013.

34.

Metal-mediated crystallization of the xylose transporter XylE from Escherichia coli in three different crystal forms.

Quistgaard EM, Löw C, Moberg P, Nordlund P.

J Struct Biol. 2013 Nov;184(2):375-8. doi: 10.1016/j.jsb.2013.09.009. Epub 2013 Sep 21.

PMID:
24060988
35.

Structural and biophysical characterization of the cytoplasmic domains of human BAP29 and BAP31.

Quistgaard EM, Löw C, Moberg P, Guettou F, Maddi K, Nordlund P.

PLoS One. 2013 Aug 13;8(8):e71111. doi: 10.1371/journal.pone.0071111. eCollection 2013.

36.

The effect of odor valence on olfactory performance in schizophrenia patients, unaffected relatives and at-risk youth.

Kamath V, Turetsky BI, Calkins ME, Bilker WB, Frishberg N, Borgmann-Winter K, Kohler CG, Conroy CG, Gur RE, Moberg PJ.

J Psychiatr Res. 2013 Nov;47(11):1636-41. doi: 10.1016/j.jpsychires.2013.07.014. Epub 2013 Aug 14.

37.

Structural insights into substrate recognition in proton-dependent oligopeptide transporters.

Guettou F, Quistgaard EM, Trésaugues L, Moberg P, Jegerschöld C, Zhu L, Jong AJ, Nordlund P, Löw C.

EMBO Rep. 2013 Sep;14(9):804-10. doi: 10.1038/embor.2013.107. Epub 2013 Jul 19.

38.

Meta-analysis of olfactory function in schizophrenia, first-degree family members, and youths at-risk for psychosis.

Moberg PJ, Kamath V, Marchetto DM, Calkins ME, Doty RL, Hahn CG, Borgmann-Winter KE, Kohler CG, Gur RE, Turetsky BI.

Schizophr Bull. 2014 Jan;40(1):50-9. doi: 10.1093/schbul/sbt049. Epub 2013 May 2.

39.

Structural basis for substrate transport in the GLUT-homology family of monosaccharide transporters.

Quistgaard EM, Löw C, Moberg P, Trésaugues L, Nordlund P.

Nat Struct Mol Biol. 2013 Jun;20(6):766-8. doi: 10.1038/nsmb.2569. Epub 2013 Apr 28.

PMID:
23624861
40.

The influence of semantic processing on odor identification ability in schizophrenia.

Kamath V, Turetsky BI, Seligman SC, Marchetto DM, Walker JB, Moberg PJ.

Arch Clin Neuropsychol. 2013 May;28(3):254-61. doi: 10.1093/arclin/act018. Epub 2013 Mar 28.

41.

High-throughput analytical gel filtration screening of integral membrane proteins for structural studies.

Löw C, Moberg P, Quistgaard EM, Hedrén M, Guettou F, Frauenfeld J, Haneskog L, Nordlund P.

Biochim Biophys Acta. 2013 Jun;1830(6):3497-508. doi: 10.1016/j.bbagen.2013.02.001. Epub 2013 Feb 9.

PMID:
23403133
42.

Olfaction and apathy in Alzheimer's disease, mild cognitive impairment, and healthy older adults.

Seligman SC, Kamath V, Giovannetti T, Arnold SE, Moberg PJ.

Aging Ment Health. 2013;17(5):564-70. doi: 10.1080/13607863.2013.768208. Epub 2013 Feb 12.

43.

Comparative accuracies of two common screening instruments for classification of Alzheimer's disease, mild cognitive impairment, and healthy aging.

Roalf DR, Moberg PJ, Xie SX, Wolk DA, Moelter ST, Arnold SE.

Alzheimers Dement. 2013 Sep;9(5):529-37. doi: 10.1016/j.jalz.2012.10.001. Epub 2012 Dec 21.

44.

Association of schizophrenia with the phenylthiocarbamide taste receptor haplotype on chromosome 7q.

Moberg PJ, Li M, Kanes SJ, Gur RE, Kamath V, Turetsky BI.

Psychiatr Genet. 2012 Dec;22(6):286-9. doi: 10.1097/YPG.0b013e32835863f0.

PMID:
22955840
45.

Optimisation of over-expression in E. coli and biophysical characterisation of human membrane protein synaptogyrin 1.

Löw C, Jegerschöld C, Kovermann M, Moberg P, Nordlund P.

PLoS One. 2012;7(6):e38244. doi: 10.1371/journal.pone.0038244. Epub 2012 Jun 1.

46.

Olfaction and schizophrenia clinical risk status: just the facts.

Turetsky BI, Kamath V, Calkins ME, Brewer WJ, Wood SJ, Pantelis C, Seidman LJ, Malaspina D, Good KP, Kopala LC, Moberg PJ.

Schizophr Res. 2012 Aug;139(1-3):260-1; author reply 262-3. doi: 10.1016/j.schres.2012.04.016. Epub 2012 May 14. No abstract available.

47.

An odor-specific threshold deficit implicates abnormal cAMP signaling in youths at clinical risk for psychosis.

Kamath V, Moberg PJ, Calkins ME, Borgmann-Winter K, Conroy CG, Gur RE, Kohler CG, Turetsky BI.

Schizophr Res. 2012 Jul;138(2-3):280-4. doi: 10.1016/j.schres.2012.03.029. Epub 2012 Apr 25.

48.

Phenylthiocarbamide (PTC) perception in ultra-high risk for psychosis participants who develop schizophrenia: testing the evidence for an endophenotypic marker.

Brewer WJ, Lin A, Moberg PJ, Smutzer G, Nelson B, Yung AR, Pantelis C, McGorry PD, Turetsky BI, Wood SJ.

Psychiatry Res. 2012 Aug 30;199(1):8-11. doi: 10.1016/j.psychres.2012.03.010. Epub 2012 Apr 14.

49.

Verbal learning and memory in older adults with minor and major depression.

Mesholam-Gately RI, Giuliano AJ, Zillmer EA, Barakat LP, Kumar A, Gur RC, McAndrew LM, Bilker WB, Elderkin-Thompson V, Moberg PJ.

Arch Clin Neuropsychol. 2012 Mar;27(2):196-207. doi: 10.1093/arclin/acr106. Epub 2011 Dec 21.

50.

Computerized neurocognitive test performance in schizophrenia: a lifespan analysis.

Irani F, Brensinger CM, Richard J, Calkins ME, Moberg PJ, Bilker W, Gur RE, Gur RC.

Am J Geriatr Psychiatry. 2012 Jan;20(1):41-52. doi: 10.1097/JGP.0b013e3182051a7d.

Supplemental Content

Loading ...
Support Center